Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dova Pharmaceuticals Inc.

www.dova.com

Latest From Dova Pharmaceuticals Inc.

New EU Approvals

The Pink Sheet’s list of EU centralized approvals of new active substances now includes four new products, one of which is Regeneron Pharmaceuticals/Sanofi’s Libtayo (cemiplimab) for treating advanced cutaneous squamous cell carcinoma. The list, which contains information dating back to January 2018, includes brand name, generic name, company, therapeutic indication, date of marketing authorization and product type (eg, medicine, vaccine, biologic).

Approvals Europe

Keeping Track: US FDA Closes Out First Half Of 2019 With CRL For Edsivo, But A Burst Of Supplemental Approvals

The latest drug development news and highlights from our US FDA Performance Tracker.

Approvals Drug Review

Double Approval Boost For Dova’s Doptelet But EU Licensee Still Sought

A first approval in the EU and an expanded US label for Dova’s TPO product should alter the its sales trajectory – all it needs now is an EU partner.

Approvals Companies

ViiV’s Potential HIV Blockbuster Among Latest Drugs To Win EMA Nod

A total of 13 new drugs have been recommended for pan-EU approval, while one has failed to meet the European Medicines Agency’s standards.

Europe Approvals
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Dova Pharmaceuticals Inc.
  • Senior Management
  • David Zaccardelli, Pres. & CEO
    Mark W Hahn, CFO
    Lee Allen, CMO
    Jason Hoitt, Chief Commercial Officer
  • Contact Info
  • Dova Pharmaceuticals Inc.
    Phone: (919) 806-4487
    240 Leigh Farm Rd., Ste. 245
    Durham, NC 27707
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register